Theravance Biopharma Inc (NASDAQ: TBPH) is -8.40% lower on its value in year-to-date trading and has touched a low of $7.44 and a high of $10.90 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The TBPH stock was last observed hovering at around $8.60 in the last trading session, with the day’s gains setting it 0.02%.
Currently trading at $8.62, the stock is -2.45% and -5.72% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.16 million and changing 0.29% at the moment leaves the stock -4.14% off its SMA200. TBPH registered -11.04% loss for a year compared to 6-month gain of 0.23%. The firm has a 50-day simple moving average (SMA 50) of $9.1434 and a 200-day simple moving average (SMA200) of $8.9921.
The stock witnessed a -8.98% loss in the last 1 month and extending the period to 3 months gives it a 2.13%, and is 2.74% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 4.01% over the week and 4.29% over the month.
Theravance Biopharma Inc (TBPH) has around 97 employees, a market worth around $431.01M and $64.38M in sales. Profit margin for the company is -87.63%. Distance from 52-week low is 15.86% and -20.92% from its 52-week high. The company has generated returns on investments over the last 12 months (-26.28%).
with sales reaching $28.07M over the same period.The EPS is expected to grow by 84.13% this year, but quarterly earnings will post 60.39% year-over-year. Quarterly sales are estimated to grow 93.58% in year-over-year returns.
181.0 institutions hold shares in Theravance Biopharma Inc (TBPH), with institutional investors hold 96.30% of the company’s shares. The shares outstanding are 49.47M, and float is at 45.88M with Short Float at 7.77%. Institutions hold 91.69% of the Float.
The top institutional shareholder in the company is MADISON AVENUE PARTNERS, LP with over 8.51 million shares valued at $72.18 million. The investor’s holdings represent 17.4603 of the TBPH Shares outstanding. As of 2024-06-30, the second largest holder is WEISS ASSET MANAGEMENT LP with 7.46 million shares valued at $63.24 million to account for 15.2975 of the shares outstanding. The other top investors are BAUPOST GROUP LLC/MA which holds 4.2 million shares representing 8.616 and valued at over $35.62 million, while BLACKROCK INC. holds 7.7547 of the shares totaling 3.78 million with a market value of $32.06 million.
Theravance Biopharma Inc (TBPH) Insider Activity
The most recent transaction is an insider sale by Farnum Rhonda, the company’s SVP, COMM & MEDICAL AFFAIRS. SEC filings show that Farnum Rhonda sold 4,000 shares of the company’s common stock on Jan 21 ’25 at a price of $9.00 per share for a total of $36000.0. Following the sale, the insider now owns 0.31 million shares.
Still, SEC filings show that on Nov 11 ’24, Farnum Rhonda (SVP, COMM & MEDICAL AFFAIRS) disposed off 4,000 shares at an average price of $9.00 for $36000.0. The insider now directly holds 322,743 shares of Theravance Biopharma Inc (TBPH).
